Genomic Diversity and Antimicrobial Resistance of Vibrio cholerae Isolates from Africa: A PulseNet Africa Initiative Using Nanopore Sequencing to Enhance Genomic Surveillance

Ebenezer Foster-Nyarko,Shola Able-Thomas,Nana Eghele Adade,Rexford Adade,Jean Claude Blessa Anne,Loretta Antwi,Yaya Bah,Gifty Boateng,Heather Carleton,David Chaima,Roma Chilengi,Kalpy Julien Coulibaly,Firehiwot Abera Derra,Dwayne Didon,Cheelo Dimuna,Mireille Dosso,Momodou M. Drammeh,Sana Ferjani,Kathryn E. Holt,Rohey Jatta,John Bosco Kalule,Abdoulie Kanteh,Hortense Faye Kette,Dam Khan,N'da Kouame Nazaire Kouadio,Christine Lee,Hamakwa Mantina,Gillan Mulenga,John Mwaba,Fatou Nyang,Godfred Owusu-Okyere,Jessica Rowland,Aissatou Seck,Abdul Karim Sesay,Anthony Smith,Peyton Smith,Djifahamai Soma,Nomsa Tau,Pierrette Landrie Simo Tchuint,Peggy-Estelle Maguiagueu Tientcheu,Chalwe Sokoni,Sabine N'dri Vakou,Delfino Vubil,PulseNet Africa
DOI: https://doi.org/10.1101/2024.12.17.628868
2024-12-18
Abstract:Objectives: Vibrio cholerae remains a significant public health threat in Africa, with antimicrobial resistance (AMR) complicating treatment. This study leverages whole-genome sequencing (WGS) of V. cholerae isolates from Cote d'Ivoire, Ghana, Zambia and South Africa to assess genomic diversity, AMR profiles, and virulence, demonstrating the utility of WGS for enhanced surveillance within the PulseNet Africa network. Methods: We analysed Vibrio isolates from clinical and environmental sources (2010-2024) using Oxford Nanopore sequencing and hybracter assembly. Phylogenetic analysis, multilocus sequence typing (MLST), virulence and AMR gene detection were performed using Terra, Pathogenwatch, and Cloud Infrastructure for Microbial Bioinformatics (CLMB) platforms, with comparisons against 88 global reference genomes for broader genomic context. Results: Of 79 high-quality assemblies, 67 were confirmed as V. cholerae, with serogroup O1 accounting for the majority (43/67, 67%). ST69 accounted for 60% (40/67) of isolates, with eight sequence types identified overall. Thirty-seven isolates formed novel sub-clades within AFR12 and AFR15 O1 lineages, suggesting local clonal expansions. AMR gene analysis revealed high resistance to trimethoprim (96%) and quinolones (83%), while resistance to azithromycin, rifampicin, and tetracycline remained low (less than or equal to 7%). A significant proportion of the serogroup O1 isolates (41/43, 95%) harboured resistance genes in at least three antibiotic classes. Conclusions: This study highlights significant genetic diversity and AMR prevalence in African V. cholerae isolates, with expanding AFR12 and AFR15 clades in the region. The widespread resistance to trimethoprim and quinolones raises concerns for treatment efficacy, although azithromycin and tetracycline remain viable options. WGS enables precise identification of species and genotyping, reinforcing PulseNet Africa's pivotal role in advancing genomic surveillance and enabling timely public health responses to cholera outbreaks.
Genomics
What problem does this paper attempt to address?